Table: RaQualia Pharma - 6-MTH group results

RaQualia Pharma

15/08/2022 07:30

Aug 15 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.45                1.32             2.61     
                   (+9.6 pct)         (+254.3 pct)      (-6.2 pct)  
  Operating          551 mln             314 mln          420 mln   
                   (+75.1 pct)                          (-40.6 pct) 
  Recurring          681 mln             432 mln          420 mln   
                   (+57.4 pct)                          (-51.3 pct) 
  Net                469 mln             302 mln          342 mln   
                   (+55.0 pct)                          (-54.7 pct) 
  EPS               22.40 yen           14.45 yen        16.34 yen  
  EPS Diluted       22.39 yen           14.45 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T